(HealthDay News) — The number of US adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the American Medical Association.

The Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application for zongertinib for the treatment of adult patients with ...

The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

The likelihood of experiencing an increase in Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index within 208 weeks was lower for patients in the ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.

Intradiscal injection of BRTX-100 during an outpatient procedure is expected to alleviate chronic low back pain arising from the damaged disc. The Food and Drug Administration (FDA) has granted ...

Findings showed treatment with SkinTE plus SOC resulted in more wound closure compared with SOC alone. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to SkinTE ...

The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies.

Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome. HealthDay News — For patients with acute coronary syndrome (ACS) undergoing drug ...

New vaccines to protect against meningococcal disease and chikungunya virus; skin prep product recalled due to fungal contamination; rapid-acting insulin biosimilar approved; and twice-yearly ...